Groupe D'etude Therapeutique Des Affections Inflammatoires Digestives

This study tests whether increasing the dose of guselkumab helps people with Crohn's disease who didn't get enough benefit from the usual dose. About 210 adults with active Crohn's will receive a higher dose (200 mg every 4 weeks) and be followed for a year. The main goal is to s…